Exclusively for subscribers of Outsourced Pharma, our content collections bundle articles centered around a particular topic or theme. These carefully curated selections feature content from both our internal team of editors as well as our subject matter experts who contribute regularly to the site.
The promise of continuous manufacturing seems almost limitless in its potential. But, what about the reality on the ground? Louis Garguilo, Chief Editor of Outsourced Pharma, looks at current continuous manufacturing initiatives underway and what’s slowing adoption.
Outsourced Pharma’s Chief Editor, Louis Garguilo, takes a deep-dive into the current state of fill-finish services in the pharmaceutical outsourcing space. He talks to executives from both sponsor and CDMO companies and helps readers understand the current challenges in fill-finish, stakeholders’ role in improving outcomes, and potential future solutions.
Partnerships between sponsor companies and contract manufacturers can take on endless variations. Louis Garguilo, Chief Editor of Outsourced Pharma explores several successful sponsor-CDMO relationships by talking to the participants involved.
Are we dangerously reliant on outsourcing to China, and is this outsourcing without the good of U.S. patients in mind? Our drug development and manufacturing outsourcing industry can’t escape the ins-and-outs of geopolitical and global affairs. Learn more in this free collection of articles